摘要
目的分析乌司他丁加大剂量氨溴索对重症肺炎的治疗效果及对血气指标水平以及6 min步行距离情况的影响。方法选择本院于2015年3月—2018年3月收治的45例重症肺炎患者为研究主体。划分为A组和B组,分别是23例与22例。A组给予乌司他丁加大剂量氨溴索治疗,B组给予常规治疗。对比临床疗效。结果 A组的治疗总有效率为95.65%,B组为72.73%(P <0.05)。治疗后,两组的血氧分压与氧合指数均升高,且A组高于B组;6 min步行距离均延长,且A组长于B组(P <0.05)。结论为重症肺炎患者行乌司他丁加大剂量氨溴索治疗可改善其血气指标和6 min步行距离,具有较佳的治疗效果。
Objective To analyze the therapeutic efect of ulinastatin and high-dose ambroxol on severe pneumonia and its infuence on blood gas index and 6 min walking distance. Methods 45 cases of severe pneumonia admitted to our hospital from March 2015 to March 2018 were selected as the research subjects. They were divided into group A and group B, which were 23 cases and 22 cases respectively. Group A was treated with ulinastatin and high-dose ambroxol, while group B was given conventional treatment. The clinical effect was compared. Results The total effective rate of group A was 95.65%, while that of group B was 72.73% （P 〈 0.05）. After treatment, the blood oxygen pressure and oxygenation index of the two groups increased, and the group A was higher than the group B. The 6 min walking distance was prolonged, and the group A was longer than group B （P 〈 0.05）. Conclusion Ulinastatin and high-dose ambroxol can improve blood gas index and 6 min walking distance for severe pneumonia patients.
作者
黄刚
HUANG Gang(Respiratory Medicine Department,Lishui District People＇s Hospital of Nanjing,Nanjing Jiangsu 211200,China)
出处
《中国继续医学教育》
2018年第31期115-116,共2页
China Continuing Medical Education
